We report on Mycobacterium tuberculosis thymidine monophosphate kinase (TMPKmt) inhibitory activities of a series of new 3'-and 5'-modified thymidine analogues including α-and β-derivatives. In addition, several analogues were synthesized in which the 4-oxygen was replaced by a more lipophilic sulfur atom to probe the influence of this modification on TMPKmt inhibitory activity. Several compounds showed an inhibitory potency in the low micromolar range, with the 5'-arylthiourea 4-thio-α-thymidine analogue being the most active one (K i = 0.17 μM). This compound was capable of inhibiting mycobacteria growth at a concentration of 25 μg/mL.
5'
Modeling experiments suggested a binding mode for these 3'-C-arylthiourea analogues that differs from that of the natural substrate in that the sugar ring of the thymidine moiety is tilted over 180° compared to that of dTMP, thereby positioning the aromatic 3'-substituent into the phosphoryl donor binding area and the nucleobase below the sugar plane ( Figure 1 ). tuberculosis (39% inhibition at 6.25 μg/mL) strains. 8 Next to the relative orientation between the aryl moiety and the nucleobase, structural exploration of the α-thymidine derivatives revealed the importance for aromatic residues at the 5'-position and the positive impact of electronic-withdrawing and lipophilic substituents on the aryl moiety for optimal inhibition of TMPKmt.
In this contribution we report on the TMPKmt inhibitory activities of a series of new thymidine analogues. Analogues 4 and 5 represent close analogues of 3'-C-arylthiourea 2, in which the methylene group between C-3' and the (thio)urea group has been omitted. 9 Analogues 8-11, derived from AZT (6) , were selected to investigate if a 1,4-disubstituted 1,2,3-triazole motif can act as a bioisostere for the 3'-C-thiourea linker of 2 as previously found to be the case for TK-2 inhibition. 10 The aminotetrazole isomers 12 and 13 were recently synthesized in the context of TK-2 inhibition 11 To assess the inhibitory activity of anomeric variants of 3, its β-anomer 14, as well as two heterocyclic analogues 15 and 16 are included in this study. Compounds 18-20 are derived from 5'-azido-5'-deoxy-α-D-thymidine (17) and synthesized in an effort to improve the activity of compound 3. To further and are also characterized by the presence of a heterocyclic linker to connect the aromatic moiety to position 3 of the 2'-deoxyribofuranose ring.
investigate the influence of the relative orientation between the aryl moiety and the nucleobases, compound 21, which is the α-analogue of 9, was synthesized and evaluated.
Based on earlier reports of 4-thiothymidine analogues showing promising antimycobacterial potency against M. bovis and M. tuberculosis in vitro and thus capable of entering the bacillus, 12 2. Results and discussion several analogues were synthesized in which the 4-oxygen of the thymine moiety was replaced by a more lipophilic sulfur atom (e.g., 7, 10, 19 and 20) to probe the influence of this modification on TMPKmt inhibitory activitity.
Chemistry
With the exception of compounds 7, 10, 14-16, 18-20 and 22, the chemical synthesis of all other final compounds has been reported before. 9, 10, 11 For the preparation of 4-thio-AZT (7), 5'-O-acetylated AZT 
Biological evaluation
All compounds have been evaluated for TMPKmt inhibition as described in the Experimental Section and results are summarized in Table 1 . Replacement of the 3'-azido group of AZT (6) by a 3-CF 3 -4-Clphenylurea substituent (4) resulted in a 10-fold increased activity, while this trend was less pronounced with the thiourea analogue 5. In the 1,4-substituted 1,2,3-triazole series, the anti-TMPKmt activity was clearly influenced by the nature of the substituent at C-4 of the triazole. The click product of AZT and phenylacetylene (8) proved to be more potent than AZT itself. p-Chloro-substitution of the phenyl ring of 8 or introduction of a methylene between the triazole and the phenyl caused a moderate increase in activity (11) . In this series of 3'-modified thymidine analogues, replacement of the oxygen at position 4 of the thymine moiety by a sulfur typically led to a significant drop in affinity for the target enzyme (compare couples 6/7 and 9/10). Compounds 12 and 13, both containing a 1,5-disubstituted tetrazole, significantly differed in their capacity to inhibit TMPKmt. The aminotetrazole analogue 13, in which the tetrazole ring is directly attached to the sugar ring, showed a significantly better activity compared to analogue 12 in which the tetrazole ring is connected to C-3' via a NH-bridge.
Remarkably, an opposite trend was observed for these tetrazole analogues on mitochondrial thymidine kinase 2.
11
The inhibitory activity of a series of 5'-modified β-thymidine analogues appeared to be weak. 
19
In addition, α-analogue 22, which was synthesized to further assess the influence of the relative orientation between the aryl moiety and the nucleobases, showed poor inhibitory activity against TMPKmt, indicating that the preferred trans-orientation of the base and the aromatic substituent also holds for the 3'-modified analogues.
Compound 19 was evaluated for its in vitro inhibitory activity against Mycobacterium bovis BCG. It showed 100% inhibition of bacterial growth at a concentration of 25 μg/mL.
In an effort to rationalize the 3-fold increase in affinity upon replacement of the 4-O of the original hit 3
by a 4-S (19), both compound were docked into the substrate binding site of the TMPKmt enzyme ( Figure 2 ). 8 The interactions of the base moiety with the surrounding residues is in inhibitor 3 are similar to the ones with the natural substrate 6 : a stacking with Phe70, H-bond of base atom N3 with Asn100 and base atom O4 hydrogen bonding with Arg74. An additional hydrogen bond involving O3'
and Tyr39 may explain the better activity of 3 compared to its 3'-deoxygenated analogue. 8 In compound 19 where the C(4)=O at is replaced by a C(4)=S, the hydrogen bonds to Arg74 is lost.
However, due to the bigger size of the sulfur atom, a better van der Waals interaction is seen with surrounding residues Phe70, Arg74 and Asn100 which may explain a higher affinity for this inhibitor. 
Experimental Section
Spectrophotometric Binding Assay. TMPKmt activities were determined using the coupled spectrophotometric assay described by Blondin et al. 
5'-O-acetyl-3'-(4-chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-4-thio-β-D-thymidine (26).

3'-(4-Chlorophenyl-1,2,3-triazol-1-yl)-3'-deoxy-4-thio-β-D-thymidine (10
N-(5'-Deoxy-β-D-thymidin-5'-yl)-N'-(4-chloro-3-trifluoromethylphenyl)-thiourea (14). Compound
28 (84 mg, 0.14 mmol) was dissolved in THF (0.9 mL). A solution of 1M tetra-nbutylammoniumfluoride in THF (0.31 mL) was added. After 1 h at room temperature the reaction was 
5-(5'-Amino-5'-deoxy-3'-O-tert-butyldimethylsilyl-β-D-thymidin-5'N-yl)-1-(4-chloro-3-trifluoromethylphenyl)-tetrazole (29).
5-(5'-Amino-5'-deoxy-β-D-thymidin-5'N-yl)-1-(4-chloro-3-trifluoromethylphenyl)-tetrazole (15).
Compound 29 (241 mg, 0.400 mmol) was dissolved in THF (2.5 mL). A solution of 1 M tetra-nbutylammoniumfluoride in THF (0.88 mL) was added. After 1 h at room temperature the reaction was completed. The solvent was evaporated and the anhydrous residue was purified by column chromatography (CH 2 Cl 2 /MeOH 95:5) to give pure compound 15 (104 mg, white solid) in 53% yield. as a white powder. 
5'-Azido-5'-deoxy-4-thio-α-D-thymidine (35). A solution of 5'-mesylated 4-thio-α-D-thymidine 34
(129 mg, 0.38 mmol) and NaN 3 (250 mg, 3.86 mmol) in DMF (7 mL) was heated to 60 °C overnight.
The reaction mixture was evaporated in vacuo. 
N-(5'-Deoxy-4-thio-α-D-thymidin-5'-yl)-N'-(3-trifluoromethyl-4-chlorophenyl)thiourea (19).
Compound 19 was synthesized from amine 36 (52 mg, 0.20 mmol) and 4-chloro-3-trifluoromethylphenyl isothiocyanate (57 mg,0.24 mmol) using the same procedure as described for NH 3 in MeOH solution (2.6 mL) and stirred at room temperature for 6 hours. The reaction mixture was concentrated in vacuo and the residue was purified on a silica gel column using EtOAc/hexane (8:2) as the eluent to afford compound 21 as a colorless solid (91 mg, 72%). 
